Eli V. Gelfand, M.D.

NPI 1659339588ActiveIndividual· Internal Medicine, Cardiovascular Disease· Boston, MA

Internal Medicine, Cardiovascular Disease (M.D.) in Boston, Massachusetts, trained at University of Illinois College of Med (Chi/Peor/Rock/Chm-Urb) (class of 2000). Their prescriptions cost Medicare Part D more than their services did: $1,654,075 for 4,830 claims, against $153,411 paid for services in 2024. Edwards Lifesciences Corporation was the largest of 2 companies reporting payments in 2025, $4,441 in all, mostly consulting fees.

Overview

NPI	1659339588
Status	Active
Entity type	Individual
Credential	M.D.
Sole proprietor	No
NPI issued	May 2, 2006
Last updated in NPPES	Jun 7, 2011

Specialties and licenses

Taxonomy	Code	License	State
Internal Medicine, Cardiovascular Disease Primary	207RC0000X	212915	MA
Internal Medicine	207R00000X	212915	MA

About license numbers in NPPES

Exclusion screening

List	Result	Details
HHS-OIG LEIE · Nov 10, 2026	No match	Checked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026	No match	—
New York OMIG · Nov 11, 2026	No match	—
Ohio Medicaid · Nov 11, 2026	No match	—
Pennsylvania Medicheck · Nov 11, 2026	No match	—
Washington HCA · Nov 11, 2026	No match	—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)	Enrolled Practitioner - Cardiovascular Disease (Cardiology) (MA)
Accepts assignment	Yes (participating)

Medicare services in 2024

Medicare patients	1,863
Services billed	4,031 across 39 procedure codes
Paid by Medicare	$153,411

Part D prescriptions in 2024

Prescriptions (claims)	4,830 · 9,252 30-day fills
Patients	603
Total drug cost	$1,654,075
Generic share	74% of claims

Medicare sources and data years

Education and affiliations

Medical school	University of Illinois College of Med (Chi/Peor/Rock/Chm-Urb)
Graduation year	2000
Medicare specialty	Cardiovascular Disease (Cardiology)
Secondary specialties	Internal Medicine
Telehealth	Offers telehealth